sellWeak cluster of 210b5-1 plan
Bryson Anna sold $5.8M of DOCS
Chief Financial Officer at Doximity, Inc.. 100,000 shares at an average of $58.42, traded Nov 12, 2024, filed Nov 14, 2024.
Warning score
30Value
$5.8M
100,000 shares
Holdings after
304,506
-30% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001516513-24-000104, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | CConversion Class A Common Stock10b5-1 | +30,000 | - | - | 334,506 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -4,051 | $57.83 | $234k | 330,455 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -6,195 | $58.82 | $364k | 324,260 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -19,754 | $59.74 | $1.2M | 304,506 | Nov 14, 2024 |
| Nov 12, 2024 | CConversion Class A Common Stock10b5-1 | +70,000 | - | - | 374,506 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -70,000 | $58.05 | $4.1M | 304,506 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 547,268 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +30,000 | $0.00 | $0 | 30,000 | Nov 14, 2024 |
| Nov 12, 2024 | CConversion Class B Common Stockderivative10b5-1 | -30,000 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -70,000 | $0.00 | $0 | 477,268 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +70,000 | $0.00 | $0 | 70,000 | Nov 14, 2024 |
| Nov 12, 2024 | CConversion Class B Common Stockderivative10b5-1 | -70,000 | $0.00 | $0 | 0 | Nov 14, 2024 |
Related signals
Other insiders at Doximity, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 31Weak | sell 210b5-1 | DOCS Doximity, Inc. | Cabral Timothy S director | $841k | 20,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.